ATE377073T1 - Modulatoren der funktion des fas/ap01 rezeptors - Google Patents

Modulatoren der funktion des fas/ap01 rezeptors

Info

Publication number
ATE377073T1
ATE377073T1 AT95944148T AT95944148T ATE377073T1 AT E377073 T1 ATE377073 T1 AT E377073T1 AT 95944148 T AT95944148 T AT 95944148T AT 95944148 T AT95944148 T AT 95944148T AT E377073 T1 ATE377073 T1 AT E377073T1
Authority
AT
Austria
Prior art keywords
fas
modulators
receptor function
proteins
protein
Prior art date
Application number
AT95944148T
Other languages
English (en)
Inventor
David Wallach
Mark Boldin
E Varfolomeev
Igor Mett
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11200294A external-priority patent/IL112002A0/xx
Priority claimed from IL112692A external-priority patent/IL112692A/en
Priority claimed from IL11461595A external-priority patent/IL114615A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE377073T1 publication Critical patent/ATE377073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmitters (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Secondary Cells (AREA)
AT95944148T 1994-12-15 1995-12-14 Modulatoren der funktion des fas/ap01 rezeptors ATE377073T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11200294A IL112002A0 (en) 1994-05-11 1994-12-15 Modulatiors of tnf/ngf superfamily receptors, their preparation and use
IL112692A IL112692A (en) 1995-02-19 1995-02-19 ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R
IL11461595A IL114615A0 (en) 1995-07-16 1995-07-16 Modulators of the function of fas receptors and other proteins

Publications (1)

Publication Number Publication Date
ATE377073T1 true ATE377073T1 (de) 2007-11-15

Family

ID=27271687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95944148T ATE377073T1 (de) 1994-12-15 1995-12-14 Modulatoren der funktion des fas/ap01 rezeptors

Country Status (17)

Country Link
EP (1) EP0871645B1 (de)
JP (1) JP3787355B2 (de)
KR (1) KR100536394B1 (de)
CN (1) CN1105725C (de)
AT (1) ATE377073T1 (de)
AU (1) AU706401B2 (de)
CA (1) CA2207815C (de)
CY (1) CY2586B2 (de)
DE (1) DE69535634T2 (de)
DK (1) DK0871645T3 (de)
ES (1) ES2292172T3 (de)
FI (1) FI121273B (de)
MX (1) MX9704501A (de)
NO (1) NO324725B1 (de)
PT (1) PT871645E (de)
UA (1) UA58489C2 (de)
WO (1) WO1996018641A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
ATE296107T1 (de) * 1995-02-22 2005-06-15 Yeda Res & Dev Modulatoren von regulationsproteinen
AU755662B2 (en) * 1995-02-22 2002-12-19 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6399327B1 (en) 1995-07-16 2002-06-04 Yeda Research And Development Co. Ltd. Modulators of the function of FAS receptors and other proteins
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
EP0842665A3 (de) * 1996-11-14 2002-12-18 Smithkline Beecham Corporation Interleukin-1-beta-konvertierendes-Enzym-ähnliche Apoptosisproteasen und ihre Agonisten
US5969102A (en) * 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
ES2181197T3 (es) * 1997-04-25 2003-02-16 Wyeth Corp Isoformas de mort1 neuronal.
AU7988698A (en) * 1997-06-26 1999-01-19 Chiron Corporation Human fadd-interacting protein (fip)
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
CA2448123C (en) 2001-05-24 2012-09-11 Zymogenetics, Inc. Taci-immunoglobulin fusion proteins
US6743630B2 (en) 2002-03-06 2004-06-01 The Trustees Of Columbia University In The City Of New York Method of preparing a protein array based on biochemical protein-protein interaction
AU2006278229B2 (en) 2005-08-09 2011-10-27 Ares Trading S.A. Methods for treating B-cell malignancies using TACI-Ig fusion molecule
WO2007019573A2 (en) 2005-08-09 2007-02-15 Zymogenetics, Inc. Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
BRPI0711823A2 (pt) 2006-05-15 2012-01-17 Ares Trading Sa métodos para tratamento de doenças auto-imunes com uma molécula de fusão taci-ig

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO178777C (no) * 1994-05-09 1996-05-29 Kvaerner Eng Varmeveksler
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein

Also Published As

Publication number Publication date
JPH10510712A (ja) 1998-10-20
NO324725B1 (no) 2007-12-03
EP0871645B1 (de) 2007-10-31
FI972457L (fi) 1997-06-10
NO972716D0 (no) 1997-06-12
CA2207815A1 (en) 1996-06-20
MX9704501A (es) 1997-10-31
CN1169729A (zh) 1998-01-07
PT871645E (pt) 2007-11-14
KR100536394B1 (ko) 2006-04-21
FI121273B (fi) 2010-09-15
EP0871645A4 (de) 1999-11-24
DK0871645T3 (da) 2007-12-03
DE69535634D1 (de) 2007-12-13
ES2292172T3 (es) 2008-03-01
FI972457A0 (fi) 1997-06-10
CN1105725C (zh) 2003-04-16
AU706401B2 (en) 1999-06-17
DE69535634T2 (de) 2008-08-28
HK1007248A1 (en) 1999-04-09
AU4602296A (en) 1996-07-03
WO1996018641A1 (en) 1996-06-20
NO972716L (no) 1997-07-11
EP0871645A1 (de) 1998-10-21
UA58489C2 (uk) 2003-08-15
CY2586B2 (en) 2009-11-04
JP3787355B2 (ja) 2006-06-21
CA2207815C (en) 2011-03-29

Similar Documents

Publication Publication Date Title
CY2586B2 (en) Modulators of the function of FAS/APO1 receptors
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
AU2894289A (en) Domain-modified constant region antibodies
GEP20022619B (en) Novel Cell Systems Having Specific Interaction of Peptide Binding Pairs
AU3192889A (en) T cell activation markers
EP1798286A3 (de) Membranproteine aus Säugetierzellen und verwandte Reagentien
EP0247730A3 (de) Antikörper, ihre Herstellung sowie Verwendung und dieselben enthaltende Produkte
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
EP1074618A3 (de) Materialien und Methoden zur Herstellung von Cadherinen
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
IL133129A0 (en) Prenylcysteine carboxyl methyltransferase dna encoding same and a method of screening for inhibistors thereof
ES8705897A1 (es) Un metodo para producir una proteina capaz de modular la actividad fisiologica de celulas que tienen receptores de diazepam.
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
AU6997794A (en) Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path
AU1908395A (en) Antibodies to mammalian natural killer antigens and uses
DE69430846D1 (de) Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
PT1062336E (pt) Moduladores da funcao de receptores da familia dos receptores tnf/ngf e outras proteinas
AU1695595A (en) Mammalian thymokine genes
AU3063699A (en) Isolated mammalian membrane protein genes and related reagents
DK0708831T4 (da) Celledensitetsforstærkede proteintyrosinphosphataser
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
WO1999047709A3 (en) Methods for identifying anti-cancer agents
DK0870015T3 (da) Xylanaser, gener, der koder for disse, samt anvendelser deraf
AU9437598A (en) Method and kit for identifying interactions between proteins or peptides
WO2000034335A3 (en) 'death domain' containing receptors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0871645

Country of ref document: EP